Cowen Inc’s Theravance Biopharma TBPH Stock Holding History

Cowen Inc’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-23,244	Closed	-$303K	–	419
2015 Q2	$303K	Buy	+23,244	New	+$360K	0.02%	290

Other funds holding TBPH

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

FAM

Foundation Asset Management White Plains, New York $116M AUM 31.02% 1-Year Est. Return

Cowen Inc's TBPH Position: Q3 2015 in Review

Cowen Inc sold out of Theravance Biopharma (TBPH) in Q3 2015, closing a stake of 23,244 shares — an estimated $303K sold.

Cowen Inc first reported a position in TBPH in Q2 2015 and held it in 1 quarter. The position peaked at $303K in Q2 2015. 83 funds tracked by Wall St. Rank hold TBPH as of Q3 2015.

Cowen Inc reported no remaining Theravance Biopharma position as of Q3 2015 after selling out during the quarter.
Cowen Inc sold 23,244 Theravance Biopharma shares in Q3 2015, an estimated $303K.
Cowen Inc first reported a position in Theravance Biopharma in Q2 2015 and held it in 1 quarter.
Cowen Inc's Theravance Biopharma position peaked at $303K in Q2 2015.
83 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.